*EMBARGOED All research presented at the 2020 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October 26, 2020, at 8:00 am EDT.

Muhammad Bashir, MD
Bashir, MD
Mohammad Nawaz, MD
Nawaz, MD
Shivakumar Vignesh, MD, FACG
Vignesh, MD, FACG

P1228 Prevalence of GI Symptoms in COVID-19 Patients and Their Impact on Clinical Outcomes, from the Epicenter of COVID-19: Multicenter Study of Academic Centers in Brooklyn

Author Insight from Muhammad H. Bashir, MD, SUNY Downstate Health Sciences University

What’s new here and important for clinicians?

  • In a predominantly minority population hospitalized with COVID-19, a third of patients presented with GI symptoms and had significantly lower all-cause mortality when compared to those presenting with non-GI symptoms.
  • Female gender was protective and mortality increased with age, disease severity, and BMI.
  • We found no significant association between ethnicity and mortality in this large multi-ethnic cohort with 78% composed of non-whites.

    What do patients need to know?

  • Risk factors for a poor outcome with COVID-19 include older age, male gender and obesity.
  • Race/ethnic background is not associated with death or poor outcomes with COVID-19.

    Read the Abstract

    Author Contact
    Muhammad H. Bashir, MD, SUNY Downstate Health Sciences University
    hassaan103 [at] gmail [dot] com

    Media Interview Requests
    To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi [dot] org or by phone at 301-263-9000.